Summary Report on Cosmetic Supervision and Sampling Inspection in China – January 2026

In January 2026, China’s National Medical Products Administration (NMPA), along with the Shandong and Guangdong Provincial Medical Products Administrations, successively issued public notices on the regulatory sampling and testing of cosmetics. A total of 61 batches of products were found to be non-compliant with relevant regulations. In addition, the Jiangxi and Shandong Provincial Medical Products Administrations released inspection reports on cosmetic manufacturers, identifying 33 enterprises with regulatory issues.

This article provides a consolidated summary of the aforementioned notices and incorporates recent developments in regulatory enforcement, including routine inspections, special inspections, and unannounced (fly-in) inspections conducted by the NMPA and several provincial authorities. The aim is to help enterprises stay informed of evolving regulatory trends and strengthen their quality management and compliance awareness.

Cosmetic Supervision and Sampling Inspection Data

NMPA Notice on 45 Batches of Non-compliant Cosmetics (2026 No. 2)

On January 19, 2026, the National Medical Products Administration (NMPA) issued a notice stating that 45 batches of cosmetics were found to be non-compliant during the 2025 national sampling and testing program for cosmetics. The testing was conducted by institutions including the Fujian Institute for Drug Control. The non-compliant products include sunscreen lotions, sunscreen sprays, and hair dyes. The issues identified involve ingredient verification, the presence of phenylmethylpyrazolone, p-phenylenediamine, and other non-compliant substances.

Notice on Cosmetic Sampling and Testing Results by Shandong Provincial MPA (2026 No. 2)

On January 9, 2026, the Shandong Provincial Medical Products Administration announced the results of a province-wide sampling and testing program for cosmetics. The inspection covered various product categories, including hair dyes, general skincare products, perfumes, whitening and spot-removal products, facial masks, and sunscreens. A total of six batches were found to be non-compliant. The non-compliance issues involved parameters such as pH value and ingredient consistency.

Notice on Cosmetic Sampling and Testing Information by Guangdong Provincial MPA (2026 Issue No. 1)

On January 9, 2026, the Guangdong Provincial Medical Products Administration released the first issue of its 2026 notice series, reporting the results of cosmetic sampling and testing conducted under the 2025 Guangdong Provincial Cosmetic Sampling and Testing Plan. The sampling covered cosmetics across production and distribution stages throughout the province.

Among the 900 batches tested, ten batches were found to be non-compliant, involving product categories such as hair gel (for dyeing) and facial masks. The non-compliance items included:

• Total bacterial count;
• Total mold and yeast count;
• Thermo-tolerant coliform bacteria;
• Triamcinolone and triamcinolone acetonide content;
• And detection of UV filters (e.g., ethylhexyl methoxycinnamate) not declared in the product’s filed technical specifications.

Regulatory Inspection of Cosmetic Manufacturers

Notice of Jiangxi MPA on the Regulatory Inspection of Cosmetic Manufacturers (No. 15 of 2024)

On January 3, 2025, the Jiangxi Medical Products Administration issued a notice stating that they had conducted regulatory inspections on eight cosmetic manufacturers. Among them, two enterprises had suspended production, two enterprises were ordered to make rectifications, and one enterprise was placed on file for investigation with a deadline for rectification.

Notice of Shandong MPA on the 2025 Regulatory Inspection Results of Cosmetic Manufacturers (No. 1 of 2026)

On January 4, 2025, the Shandong Medical Products Administration issued a notice that they have organized regulatory inspections of 27 licensed manufacturing enterprises. Among them, four enterprises were found to have suspended production at the time of inspection. For the problems identified during the inspections of the 27 enterprises, the relevant enterprises have been ordered to complete rectifications within a specified time, with supervision to ensure that rectifications are implemented, and to urge enterprises to maintain continuous and stable production quality management.

Notice of Jiangxi MPA on the Regulatory Inspection of Cosmetic Manufacturers (No. 1 of 2025)

On January 23, 2025, the Jiangxi Medical Products Administration issued a notice stating that they had conducted regulatory inspections on four cosmetic manufacturers. Among them, three were found to be basically compliant with requirements, and one was ordered to make rectifications.

Unannounced inspection

Notice of the NMPA on the Results of the Surprise Inspection of Anhui Telunsak Biotechnology Research Co., Ltd. (No. 1 of 2026)

On January 8, 2026, the NMPA issued a notice stating that they had conducted a surprise inspection of Anhui Telunsak Biotechnology Research Co., Ltd. Upon investigation, it was found that the company had violated the provisions of the Cosmetics Supervision and Administration Regulation and the Good Manufacturing Practices for Cosmetics, among other relevant regulations. The company’s production quality management system was found to have serious deficiencies.

In order to ensure the safety of cosmetics used by the public, the NMPA has instructed the Anhui Medical Products Administration to investigate and deal with the company’s suspected violations in accordance with the law. At present, the Anhui Medical Products Administration has filed a case for investigation against the company, ordered it to suspend production and business operations, and required it to rectify the identified problems.

If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.

Our Services

• China Cosmetics Registration and Filing
• China New Cosmetic Ingredients Registration and Filing
• China Toothpaste Filing
• China Cosmetics Safety and Efficacy Test
• Being a Domestic Responsible Person
• Safety Evaluation Report
• Cosmetic Ingredient Quality and Safety Info Code Application
• Formula/Label/Ingredient Review
• Regulatory Consulting/Reporting/Training
• Custom Clearance